NASDAQ:ADAP
Delisted

Adaptimmune Therapeutics Stock News

etoro logo Buy ADAP
*Your capital is at risk
$0.0549
+0 (+0%)
At Close: Feb 20, 2026

Hunting For Bargains In The Nasdaq 100

04:09pm, Monday, 03'rd Aug 2020
Analysis of NASDAQ 100 yields 23 stocks trading below 200-Day SMA. Micron and Western Digital may have room to run in second half of CY 2020.
Market Overview Analysis by JFD Team covering: Nikkei 225, Crude Oil WTI Futures, United States Oil Fund, LP. Read JFD Team's latest article on Investing.com
Second-quarter earnings season continues with results from Disney, T-Mobile, Fox, ViacomCBS, and Clorox. Video-game makers Take-Two and Activision Blizzard also report. Plus, July jobs data.
In a year in which airlines have gotten hammered by the pandemic, a carrier with ultralow costs and flexible scheduling takes the lead. Not that the flight may not get a little rough.
Frappé de plein fouet par la crise que traverse le transport aérien, ADP réduit ses coûts et ses investissements pour revenir dans le vert dès 2021. Le groupe veut réduire la masse salariale et
Final earnings conference call transcript of ADP - ADP stock

Introducing The Pale Blue Portfolio

09:20pm, Wednesday, 29'th Jul 2020
The Pale Blue Portfolio prioritizes corporate responsibility and growth at a reasonable price. It limits the investing universe to companies that receive at least an A grade from MSCI's ESG database.
Selon le ministre délégué aux Transports Jean-Baptiste Djebbari, la crise sanitaire, qui a provoqué un effondrement du trafic aérien, impose de revoir "en profondeur" le projet d'extension du ter
Sens announcement for SPEAR REIT LIMITED – Results Of The Annual General Meeting - SENS
PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 23, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, announced that the European Medici
PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 22, 2020 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in cell therapy to treat cancer, will report financial results and
Vident Investment Advisory LLC acquired a new stake in shares of Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) in the second quarter, according to the company in its most recent 13F filing with the S
Zacks Investment Research upgraded shares of Adaptimmune Therapeutics (NASDAQ:ADAP) from a hold rating to a buy rating in a report released on Tuesday morning, Zacks.com reports. Zacks Investment Rese
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE